Abstract
Ziel: Es wurden 12-Monats-Prävalenzen geschätzt bezüglich a) der Wahrnehmung substanzbezogener Probleme, b) der Inanspruchnahme verschiedener Hilfsangebote und c) der Inanspruchnahme professioneller Hilfe. Faktoren, die mit der Inanspruchnahme von Hilfe assoziiert sind, wurden analysiert. Methodik: Die Auswertung basiert auf Daten des Epidemiologischen Suchtsurveys (ESA) 2012 (n = 9084; 18 – 64 Jahre; Ausschöpfungsrate 53.6 %). Missbrauch und Abhängigkeit nach DSM-IV wurden anhand des M-CIDI erfasst. Prädiktoren der Hilfesuche wurden regressionsanalytisch getestet. Ergebnisse: Zwischen 6 % (Alkohol) und 19 % (illegale Drogen) der Konsumenten berichteten substanzbezogene Probleme. Von diesen nahmen 14 % (Alkohol), 33 % (Illegale Drogen) bzw. 59 % (Medikamente) Hilfe in Anspruch. Mit Ausnahme des Einkommens bei Alkoholkonsumenten waren soziodemografische Variablen nicht mit der Inanspruchnahme von Hilfe assoziiert. Schlussfolgerungen: Die Studie zeigt eine Unterversorgung von Personen mit substanzbezogenen Problemen. Das Hilfesuchverhalten scheint hauptsächlich durch die Schwere der substanzbezogenen Störung beeinflusst zu sein.
Aims: It was aimed to estimate 12-months prevalences of i) perception of substance-related problems among alcohol, illicit drugs and prescription drug users; ii) use of several formal and informal sources of care by individuals perceiving substance-related problems; and iii) use of professional help among individuals with a substance use disorder. Factors associated with help-seeking were assessed. Methods: Data come from the 2012 Epidemiological Survey of Substance Abuse (ESA; n = 9084; 18 to 64 years; response rate 53.6 %). DSM-IV diagnoses were assessed using the M-CIDI. Regression analyses were used to assess predictors of help-seeking. Results: Between 6 % (alcohol) and 19 % (illicit drugs) of substance users reported having experienced substance related problems. Of those, 14 % (alcohol), 33 % (illicit drugs) and 59 % (prescription drugs) sought help. With the exception of income, socio-demographic variables were not associated with help-seeking. Conclusions: Results show a clear under-treatment in individuals with substance related problems. Help-seeking seems to be mainly influenced by the severity of the substance-related disorder.
Literatur
1994). DSM-IV Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
(1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36, 1–10.
(2009). Changing health behaviour of young women from disadvantaged background: Evidence from systematic reviews. Proceedings of the Nutrition Society, 68, 195–204.
(1995). Social support and prevention of relapse following treatment for alcohol abuse. Research on Social Work Practice, 5, 283–296.
(2012). Past-year acute behavioral health care utilization among individuals with mental health disorders: Results from the 2008 National Survey on Drug Use and Health. Journal of Dual Diagnosis, 8, 19–27.
(2012). Die Anerkennung der Tabakabhängigkeit als Krankheit – ein längst fälliger Schritt oder ein Kampf gegen Windmühlen? SUCHT, 58, 153–155.
(2006). Alcohol consumption and health-services utilization in Germany. Journal of Studies on Alcohol, 67, 429–435.
(2000). Remission ohne formelle Hilfen und Inanspruchnahme stationärer Behandlung bei Alkoholabhängigen: Ein Vergleich auslösender Faktoren. SUCHT, 46, 54–61.
(2009). The effects of social identity and perceived autonomy support on health behaviour within the theory of planned behaviour. Current Psychology, 28, 55–68.
(2009). Perceived need for mental health care and service use among adults in Western Europe: Results of the ESEMeD Project. Psychiatric Services, 60, 1051–1058.
(2007). Alcohol treatment utilization: Findings from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence, 86, 214–221.
(2005). ”Yes, Ive received treatment”: What does this mean in the context of epidemiological surveys for alcohol problems? Contemporary Drug Problems, 32, 457–465.
(2005). Recovery from DSM-IV alcohol dependence: United States, 2001–2002. Addiction, 100, 281–292.
(2012). Factors associated with first utilization of different types of care for alcohol problems. Jounal of Studies on Alcohol and Drugs, 73, 647–656.
(2012). Who seeks care where? Utilization of mental health and substance use disorder treatment in two national samples of individuals with alcohol use disorders. Journal of Studies on Alcohol and Drugs, 73, 635–646.
(2004). Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, 109(Suppl. 420), 47–54.
(2013). Motivation for change and barriers to treatment among young cannabis users. European Addiction Research, 19, 29–41.
(2003). Course of alcoholism in homeless men in Munich, Germany: Results from a prospective longitudinal study based on a representative sample. Substance Use and Misuse, 38, 395–427.
(2011). Medikamente – Psychotrope und andere Arzneimittel mit Missbrauchs- und Abhängigkeitspotential. In Deutsche Hauptstelle für Suchtfragen e.V. (Hrsg.), Jahrbuch Sucht 2011 (S. 73–108). Geesthacht: Neuland.
(2009). Influence of gender, sexual orientation, and need on treatment utilization for substance use and mental disorders: Findings from the California Quality of Life Survey. BMC Psychiatry, 9, 52–61.
(2013). Riskanter Alkoholkonsum und Rauschtrinken unter Berücksichtigung von Verletzungen und der Inanspruchnahme alkoholspezifischer medizinischer Beratung. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt, 56, 809–813.
(2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Archives of General Psychiatry, 64, 830–842.
(2009). Versorgung Suchtkranker in Deutschland: Ergebnisse der Suchthilfestatistik 2007. SUCHT, 55, 15–34.
(1998). Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse. The Journal of Mental Health Policy and Economics, 1, 23–29.
(1992). The economic benefits of alcoholism treatment: A summary of twenty years of research. Journal of Employee Assistance Research, 1, 63–82.
(2010). Zusammenhang zwischen Verschreibungsverhalten der Ärzte und Medikamentenabhängigkeit ihrer Patienten. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz, 53, 319–325.
(2011). Longitudinal predictors of addictions treatment utilization in treatment-naïve adults with alcohol use disorders. Drug and Alcohol Dependence, 113, 215–221.
(2002). Benzodiazepine – immer noch zu lange und zu hoch dosiert. Sucht Aktuell, 2, 5–10.
(2001). Logistic regression in rare events data. Political Analysis, 9, 137–163.
(2013). Pressure and help seeking for alcohol problems: Trends and correlates from 1984 to 2005. Addictive Behaviors, 38, 1740–1746.
(2007). Damit Alkohol nicht zur Sucht wird – kontrolliert trinken. Stuttgart: Trias.
(2011). Selbstkontrollierte Reduktion des Drogenkonsums. Frankfurt a. M.: idh Integrative Drogenhilfe e.V.
(2013). German medical students beliefs about how best to treat alcohol use disorder. European Addiction Research, 19, 245–251.
(2013). Studiendesign und Methodik des Epidemiologischen Suchtsurveys 2012. SUCHT, 59, 309–320.
(2010). Epidemiologie des Substanzkonsums und der Suchterkrankungen in Deutschland. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz, 53, 271–283.
(2012). Gesundheitsfürsorge, §§ 56–66, 158. In , Kommentar zum Strafvollzugsgesetz (S. 381–407). Köln: Carl Heymanns Verlag.
(2008). Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addictive Behaviors, 33, 1297–1305.
(2012). Clinical recognition and recording of alcohol disorders by clinicians in primary and secondary care: Meta-analysis. The British Journal of Psychiatry, 201, 93–100.
(2005). Use of speciality substance abuse and mental health services in adults with substance use disorders in the community. Drug and Alcohol Dependence, 78, 345–354.
(2011). Tabakattributable Mortalität in Deutschland und in den deutschen Bundesländern – Berechnungen mit Daten des Mikrozensus und der Todesursachenstatistik. Gesundheitswesen, 73, 238–246.
(2010). Perceived need for care, help seeking, and perceived barriers to care for alcohol use disorders in a national sample. Psychiatric Services, 61, 1223–1231.
(2006). Why people enter treatment for alcohol problems: Findings from UK Alcohol Treatment Trial pre-treatment interviews. Journal of Substance Use, 11, 161–176.
(2013). Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012. SUCHT, 59, 321–331.
(2006). Substance use and substance use disorders in a community sample of adolescents and young adults: Incidence, age effects and patterns of use. European Addiction Research, 12, 187–196.
(2004). Problematischer Konsum illegaler Substanzen, Hilfesuchverhalten und Versorgungsangebote in einer Region. Suchtmedizin, 6, 22–31.
(2013). Komorbide Substanzstörungen in der erwachsenen Allgemeinbevölkerung. SUCHT, 59, 347–354.
(2011). A literature review of cost-benefit analyses for the treatment of alcohol dependence. International Journal of Environmental Research and Public Health, 8, 3351–3364.
(1983). Stages and processes of self-change of smoking: Toward an intergrative model of change. Journal of Consulting and Clinical Psychology, 51, 390–395.
(2012). Alcohol consumption, alcohol dependence, and attributable burden of disease in Europe: Potential gains from effective interventions for alcohol dependence. Toronto, ON: Centre for Addiction and Mental Health.
(2001). Physicians low detection rates of alcohol dependence or abuse: A matter of methodological shortcomings? General Hospital Psychiatry, 23, 133–137.
(2000). Inanspruchnahme suchtspezifischer Hilfen von Alkoholabhängigen und -mißbrauchern: Ergebnisse der TACOS-Bevölkerungsstudie. SUCHT, 46, 9–17.
(1998). Diagnostische Kriterien DSM-IV. Göttingen: Hogrefe.
(2011). Self-stigma in alcohol dependence: consequences for drinking-refusal self-efficacy. Drug and Alcohol Dependence, 114, 12–17.
(2010). Einstellung der Bevölkerung zu Alkoholkranken. Psychiatrische Praxis, 37, 111–118.
(2004). Psychologie des Gesundheitsverhaltens: Einführung in die Gesundheitspsychologie. Göttingen: Hogrefe.
(2012). German medical students lack knowledge of how to treat smoking and problem drinking. Addicition, 107, 1878–1882.
(2004). Konsum von Cannabis, Ecstasy und Amphetaminen – Gibt es einen suchtspezifischen Hilfebedarf? SUCHT, 50, 164–171.
(2013). Role of social support in lifestyle-focused weight management interventions. European Journal of Clinical Nutrition, 59, S179–S186.
(2013). Changes in cancer incidence attributable to tobacco smoking in Germany, 1999–2008. International Journal of Cancer. Advance online publication. DOI: 10.1002/ijc.28392
(1995). Münchener Composite International Diagnostic Interview (M-CIDI, Paper-pencil 2.2, 2/95). München: Max-Planck-Institut für Psychiatrie, Klinisches Institut.
(